台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股▼0.26%
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-元大-台南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-台南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/2200.00656.3055.50-6471-1.27%
2025/04/17458.8000.0058.6044890.82%
2025/04/15459.9000.0060.1044900.81%
2025/04/111159.9200.0059.20114932.23%
2025/04/1000.00156.3056.30-1488-0.20%
2025/04/09149.9000.0051.2014910.20%
2025/04/0700.00160.0060.00-1487-0.20%
2025/03/3100.00267.9067.50-2561-0.36%
2025/03/26475.2500.0074.7045770.69%
2025/03/190.373.2000.0072.600.35980.05%
2025/03/180.175.7000.0075.500.16020.01%
2025/03/17578.1000.0077.5056160.81%
2025/03/1415.278.1300.0077.7015.26172.46%
2025/03/13077.5000.0081.0006030.00%
2025/03/11182.90278.9081.50-1557-0.18%
2025/03/1000.00276.8076.80-2518-0.39%
2025/03/0300.00169.3069.60-1483-0.21%
2025/02/25168.3000.0067.7015030.20%
2025/02/21669.5000.0067.8065081.18%
2025/02/20169.7000.0071.0014970.20%
2025/01/17259.00160.2058.6016160.16%
2025/01/15361.1000.0061.0036160.49%
2025/01/13164.7000.0062.8016270.16%
2025/01/1000.00164.8065.40-1624-0.16%
2025/01/0900.00062.3061.200617-0.01%
2025/01/06164.6000.0065.1016230.16%
2025/01/0300.00163.5062.60-1631-0.16%
2024/12/3000.00166.2066.70-1692-0.14%
2024/12/27164.80161.8063.3006970.00%
2024/12/26368.00267.0566.6016920.14%
2024/12/25374.0000.0074.0036830.44%
2024/12/19163.1000.0062.7016950.14%
2024/12/1800.00260.9060.90-2678-0.29%
2024/12/1300.00353.2054.90-3678-0.44%
2024/12/1200.00355.0754.90-3678-0.44%
2024/12/11954.931055.4054.90-1666-0.15%
2024/12/06264.2000.0064.3026510.31%
2024/12/05166.4000.0065.5016550.15%
2024/12/04166.9000.0067.0016550.15%
2024/12/02167.1000.0066.6016630.15%
2024/11/27168.0000.0066.5016770.15%
2024/11/26469.75169.0068.6036810.44%
2024/11/25972.0000.0071.9096811.32%
2024/11/22171.00173.7073.0006720.00%
2024/11/21168.20267.5068.00-1662-0.15%
2024/11/20168.70167.9067.4006660.00%
2024/11/19168.00167.2067.4006670.00%
2024/11/18167.20167.2067.0006760.00%
2024/11/15366.5000.0066.0036780.44%
2024/11/1400.00166.6069.00-1670-0.15%
2024/11/13663.4300.0064.0066520.92%
2024/11/12464.93267.0570.0026320.32%
2024/11/11270.1500.0070.1026060.33%
2024/11/08177.8000.0077.8016030.17%
2024/11/0400.00190.1091.80-1637-0.16%
2024/11/0100.00094.8091.5006530.00%
2024/10/2800.00195.8095.50-1688-0.15%
2024/10/251102.501101.00100.0006870.00%
2024/10/2400.001102.00102.50-1697-0.14%
2024/10/221102.001104.50107.0007260.00%
2024/10/181114.390112.00110.0017680.13%
2024/10/1700.001119.50122.00-1779-0.13%
2024/10/111115.001119.00114.5008240.00%
2024/10/0900.001113.50119.00-1838-0.12%
2024/10/0800.000128.00126.0008390.00%
2024/10/071116.501117.00116.5008300.00%
2024/10/0400.002106.50106.50-2813-0.25%
2024/10/01097.2000.0097.2007870.01%
2024/09/272120.7500.00120.0027960.25%
2024/09/261133.5000.00133.0017850.13%
2024/09/251144.0000.00147.5017840.13%
2024/09/241160.501168.50159.0007890.00%
2024/09/232158.001158.50158.0017940.13%
2024/09/201172.5000.00169.0017820.13%
2024/08/2000.000218.00216.0008060.00%
2024/08/190194.0000.00201.5008200.00%
2024/08/1200.000200.50198.0008350.00%
2024/07/1900.001189.50182.00-1650-0.15%
2024/07/1800.002.1188.66196.50-2.1611-0.34%
2024/07/172176.5500.00191.0025890.34%
2024/07/160.1174.5000.00174.500.15660.01%
2024/07/1200.009158.67162.00-9544-1.65%
2024/07/1100.007153.50149.00-7531-1.32%
2024/07/102149.0016147.38152.50-14512-2.73%
2024/07/0900.005139.50139.00-5499-1.00%
2024/07/0300.002125.00124.50-2474-0.42%
2024/06/241107.504102.63103.00-3368-0.81%
2024/06/2100.000.1105.00106.00-0.1368-0.03%
2024/06/141097.2000.0098.60103293.03%
2024/06/12198.1000.0097.4013270.31%
2024/06/061095.0000.0095.00103183.14%
2024/06/04496.0000.0096.0043161.26%
2024/05/31893.0000.0091.8083172.52%
2024/05/29897.8100.0094.5083192.50%
2024/05/2400.00599.90105.00-5298-1.67%
2024/05/2300.00599.00100.50-5286-1.74%
2024/05/2000.003085.5786.30-30238-12.58%
2024/05/1700.003378.3578.50-33229-14.39%
2024/05/130.375.5000.0074.000.32580.11%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音